CGT-Specific Clinical Research

INTRODUCTION
Boji Medical Technology Co., Ltd.(BOJIMED) offers significant advantages in cell and gene therapy (CGT) services. The company brings together a team of multiple review experts with CDE backgrounds, who provide professional guidance on declaration strategy, clinical medical planning, and other aspects.
To better achieve precise services for CGT projects, BOJIMED has established a specialized subsidiary dedicated to the CGT field, ensuring the smooth and reliable project execution. Leveraging experience from over 50 CGT projects, BOJIMED has built a comprehensive, full-life cycle service system that spans IND declaration, clinical research, and NDA filings—offering CGT companies truly integrated, on-demand "one-stop" solutions.
To better achieve precise services for CGT projects, BOJIMED has established a specialized subsidiary dedicated to the CGT field, ensuring the smooth and reliable project execution. Leveraging experience from over 50 CGT projects, BOJIMED has built a comprehensive, full-life cycle service system that spans IND declaration, clinical research, and NDA filings—offering CGT companies truly integrated, on-demand "one-stop" solutions.
OUR ADVANTAGES
SERVICE CONTENT

Preclinical Project Consulting
- •Project development planning
- •Pharmaceutical research
- •Pharmacodynamic research
- •Pharmacokinetic research
- •Safety evaluation tests

IND Registration and Declaration
- •Preparation and application of
- Pre-IND meeting materials
- •Compilation and review of declaration documents (covering modules such as clinical trial plans, protocols, risk control plans, etc.)
- •Response to CDE technical reviews and supplementary materials

Clinical Operation
- •Screening of research centers, project approval, and pre-approval of ethics
- •Rapid initiation and monitoring
- services for trial centers
- •Subject recruitment and compliance management
- •Data management and statistical analysis
- •Pharmacovigilance management
- •Clinical trial site management services

Filed Clinical Development
- •Support the declaration of cell therapy as medical technologies, facilitating registration in the National Health Commission's stem cell research filing system and managing the ethical review process with Provincial Health Commission and medical ethics committees.